To address the European Commission's concerns about its proposed $13.4 billion acquisition of Biomet, Zimmer Holdings has proposed the divestiture of "one unicompartmental knee brand and one elbow brand" in the European Economic Areas as well as "one total knee brand" in two European countries.
Chino Valley Medical Center is the first hospital to write a requirement for use of the Leaf Patient Monitoring System to prevent pressure ulcers into its patient safety protocols.
The FDA gave HeartFlow de novo clearance Monday for its FFRCT technology, the first and only noninvasive imaging technology for coronary artery disease (CAD) that shows the extent of a blockage and how it affects blood flow. HeartFlow FFRCT could potentially change the way that CAD is diagnosed and managed.
British healthcare group BTG is snatching up interventional pulmonology outfit PneumRx in a deal worth up to $475 million, getting its hands on the company's device for severe emphysema and diversifying its product offerings.
As the holiday shopping season begins to hit fever pitch in the coming weeks, Kinsa Health's smartphone-connected thermometer will be available at Apple and CVS stores across the U.S. so you can keep tabs on you or your loved-one's temperature while you're on the move.
iRhythm has received a CE mark in Europe for its continuous heart monitoring Zio Service. The technology enables up to 14 days of continuous heart monitoring via a wireless patch; it includes analytical software, as well as report to the physician. In addition, iRhythm has partnered with cardiology distributor CardioLogic to market Zio in the U.K. for the diagnosis of atrial fibrillation and other cardiac arrhythmias.
Conventus Orthopaedics received $24 million in its first equity financing that will go to launch its distal radius fracture implant as well as to advance other minimally invasive complex fracture treatments.
Illumina and Sequenom settled the score in the companies' ongoing patent feud, agreeing to resolve all pending infringement claims and pool their resources to further develop noninvasive prenatal tests.
Physicians can add another tool to their arsenal that targets chronic back pain locally, without requiring surgery or an external device. The FDA has cleared Stimwave's Freedom Spinal Cord Stimulation System, which the company says is the smallest available neuromodulation device.
Transcatheter heart valve developer Direct Flow Medical raked in $32 million in a recent financing round
A new study supports the effectiveness of 3-D mammography, which researchers found has the potential to significantly increase the rate of identifying cancer in women with dense breasts who are screened using the digital technology.
Swiss med tech Xeltis has raised €27 million ($34 million) in an oversubscribed Series B round. The financing will be used mostly to help get its first product to market, a biodegradable pulmonary valve intended for patients with severe congenital malformations of the heart, an orphan pediatric indication.
Medtronic has sold $17 billion in bonds to fund its $43 billion acquisition of Covidien that's still expected to close early next year. The medical device giant had been expecting to fund the deal mostly with ex-U.S. cash, but opted instead for debt in order to avoid potential issues with U.S. regulators seeking to crack down on tax inversion deals.
Masimo has gained FDA clearance for its wireless, wearable patient monitor, Radius-7. The device connects to Root, Masimo's open architecture, patient monitoring and connectivity platform that links a variety of devices regardless of company origin, which the company expects to be ubiquitous.
Siemens Healthcare Diagnostics' device measuring bacteria to determine antibiotic treatment was recalled because of misreported results.
Roche is diving into the prenatal testing business, snatching up Ariosa Diagnostics to expand its diagnostics offerings and to get its hands on the company's noninvasive prenatal test for genetic abnormalities.
Edison Nation Medical and Mount Sinai Health System have struck a partnership focused on bringing medical device and other healthcare-related inventions to market.
The U.S. Food and Drug Administration has approved the Animas Vibe, a combination insulin pump and continuous glucose monitor. It allows patients with Type 1 diabetes to monitor blood glucose levels and adjust insulin delivery based on that data.
Medtronic scored EU regulatory approval for its $43 billion acquisition of Covidien, days after U.S. antitrust authorities signed off on the deal subject to certain conditions.
Rumors have been circulating in recent weeks that the French CEO of Smith & Nephew, Olivier Bohuon, would jump ship to run Paris-based Sanofi. But Bohuon told employees at a town hall meeting that he is "very happy" at Smith & Nephew, and several people with knowledge of the matter said he isn't planning to leave.